Where the money goes: Developing novel treatments to help patients quit tobacco products

Amanda Palmer, Ph.D.’s goal as a researcher is to develop and test treatments for quitting new tobacco products, like e-cigarettes. Thanks to LOWVELO rider-raised funds her research is providing a roadmap of what health effects should be looked at in treatment studies. This helps Palmer find the best ways to help people stop using tobacco and learn more about how their bodies benefit from quitting.

LOWVELO funding allows Hollings Cancer Center researchers to study depression in cancer survivors

Data shows that one in four cancer survivors suffers from depression, which can lead to decreased physical and social functioning, a lower quality of life and reduced survival rates. This is why a team of MUSC Hollings Cancer Center researchers, with funding from LOWVELO, is working to reduce depression among a growing population of survivors and improve their quality of life.

Where the money goes: researcher using LOWVELO funds to revolutionize treatment for solid tumors

Most people don’t have a positive reaction to seeing blood. But MUSC Hollings Cancer Center researcher Leonardo Ferreira, Ph.D. isn’t most people. “Every time I look at a drop of blood, I see cells screaming to be weaponized against cancer.” Ferreira’s lab hopes to bring CAR-T cell therapy, a game-changing treatment showing success in liquid tumors to solid tumors.